Tempus AITEM stock surged to a record high Monday after the Food and Drug Administration cleared its new device to help ...

Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD device.

With the AI healthcare market forecast to top $800 billion, can Tempus claim just 2.5% of that? It’s possible, especially if ...

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR ...

That’s where Tempus AI (TEM) enters the picture. Going public just last year, Tempus is already experiencing sharp revenue ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the 11 Best Performing IPOs in the Last 2 Years. The stock’s price target is raised ...

Tempus AI's strategic deals and the Paige acquisition create a deep, defensible data moat. Read why I recommend building positions on pullbacks of TEM stock.

Tempus AI Inc. shares rose after it said it received 510 (k) clearance from the Food and Drug Administration for its RNA-based in vitro diagnostic device. Its stock recently rose 5.2% to $92.85 in ...

The stock of healthcare-focused artificial intelligence company Tempus AI ( TEM 13.26%) was the cure for aching portfolios on ...

On Tuesday, Cathie Wood-led Ark Invest sold shares of Tempus AI Inc (NASDAQ: TEM) through ARK Genomic Revolution ETF (ARKG) ...

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock surged 16% Thursday morning following the company’s announcement that it received 510 (k) clearance from the U.S. Food and Drug Administration for ...